Title:
【発明の名称】子宮内膜症の処置における抗VEGF因子の使用
Document Type and Number:
Japanese Patent JPH10505321
Kind Code:
A
Abstract:
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatment of endometriosis comprising an agent which inhibits the activation and/or recruitment of peritoneal macrophages, and a physiologically acceptable carrier; and method of making the compositions and their use in the treatment of endometriosis.
Inventors:
Charnock-Jones, David Stephen
John McLaren
Andrew, Prentiss
Smith, Stephen Kevin
John McLaren
Andrew, Prentiss
Smith, Stephen Kevin
Application Number:
JP50049395A
Publication Date:
May 26, 1998
Filing Date:
May 26, 1995
Export Citation:
Assignee:
Metris Therapeutics Limited
International Classes:
A61K31/00; A61K31/135; A61K31/138; A61K31/56; A61K31/57; A61K31/70; C12P21/08; A61K38/17; A61K38/19; A61K39/395; A61K45/00; A61P13/02; A61P15/00; C07K16/24; (IPC1-7): A61K45/00; A61K31/135; A61K31/56; A61K31/70; A61K39/395
Attorney, Agent or Firm:
Shusaku Yamamoto